Policymakers and Payers

Provides a broad set of recommendations to prevent, treat, and support recovery from opioid misuse and addiction in Alaska.

Highlights the use of MAT for opioid use disorder in drug courts, reviews effective medications, and provides strategies to increase the use of MAT in drug court programs.

Reviews the current knowledge and gaps in understanding regarding the effectiveness of MAT for treating OUD, examines the circumstances in which MAT can be effectively delivered, and identifies challenges in implementation.

Gives an overview of data on the use of sublingual and transmucosal buprenorphine for MAT of OUD. Discusses the implications of using MAT in recovery support.

Includes profiles for all 50 States that detail the State authority for controlled substances and links to any relevant regulations, rules, and prescription drug monitoring programs.

Describes Virginia's Prescription Monitoring Program, including benefits, user testimonials, an informational brochure, and program milestones. Features statistical data about use of the program and prescription drugs, changes in regulations for registered system users, and feature articles for patients.

Equips local health department staff to respond to manifestations of this epidemic in their own towns and cities and provides a one-stop reference guide of promising practices, information, knowledge gleaned from the field, tools, and training.

Describes service delivery models and corresponding rate design tools for the provision of MAT to individuals with opioid dependence.

Addresses concerns about prescription drug abuse and maternal-fetal exposure to opioids.

Equips healthcare providers, communities, and local governments with material to develop practices and policies to help prevent opioid-related overdoses and deaths. Addresses issues for healthcare providers, first responders, treatment providers, and those recovering from opioid overdose.